Man Group
ADMA icon

Man Group’s ADMA Biologics ADMA Stock Holding History

Man Group’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-24,319
Closed -$357K – 2230
2025
Q3 		$357K Sell
24,319
-104,099
-81% -$1.78M ﹤0.01% 1954
2025
Q2 		$2.34M Sell
128,418
-29,727
-19% -$606K ﹤0.01% 1346
2025
Q1 		$3.14M Sell
158,145
-587,155
-79% -$10.2M 0.01% 1192
2024
Q4 		$12.8M Buy
745,300
+561,507
+306% +$10.6M 0.03% 634
2024
Q3 		$3.67M Buy
+183,793
New +$2.86M 0.01% 1131
2024
Q2 		– Sell
-25,598
Closed -$169K – 2007
2024
Q1 		$169K Buy
+25,598
New +$140K ﹤0.01% 2032
2022
Q2 		– Sell
-91,717
Closed -$168K – 2028
2022
Q1 		$168K Buy
+91,717
New +$143K ﹤0.01% 1973

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Man Group's ADMA Position: Q4 2025 in Review

Man Group sold out of ADMA Biologics (ADMA) in Q4 2025, closing a stake of 24,319 shares — an estimated $357K sold.

Man Group first reported a position in ADMA in Q1 2022 and held it in 7 quarters. The position peaked at $12.8M in Q4 2024. 356 funds tracked by Wall St. Rank hold ADMA as of Q4 2025.

  • Man Group reported no remaining ADMA Biologics position as of Q4 2025 after selling out during the quarter.
  • Man Group sold 24,319 ADMA Biologics shares in Q4 2025, an estimated $357K.
  • Man Group first reported a position in ADMA Biologics in Q1 2022 and held it in 7 quarters.
  • Man Group's ADMA Biologics position peaked at $12.8M in Q4 2024.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q4 2025.

Based on Man Group's 13F filing for Q4 2025, filed 17 Feb 2026.